XULANE 150 ug/d (Norelgestromin and Ethinyl Estradiol PATCH) 150 ug/d

Xulane 150 mcg/d is a transdermal contraceptive patch containing norelgestromin and ethinyl estradiol. It is designed for birth control and is applied weekly. Learn more about its uses and effects.

Strength

150 ug/d

Pack Size

3 POUCH in 1 CARTON (0378-3340-53) / 1 PATCH in 1 POUCH (0378-3340-16) / 7 d in 1 PATCH

Manufacturer / TM Owner

Mylan Pharmaceuticals Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Xulane 150 mcg/d is primarily used for contraception. This transdermal patch releases hormones through the skin to prevent ovulation and fertilization. It is applied once a week for three weeks, followed by a week without the patch. Many people use Xulane as a convenient and effective method of birth control.

Side Effects

Common effects of Xulane 150 mcg/d may include skin irritation at the application site, nausea, headache, and breast tenderness. Some users may experience changes in menstrual bleeding patterns. These effects vary among individuals and are not experienced by everyone.

Precautions & Warnings

Xulane 150 mcg/d should be used with caution in individuals with a history of blood clots, high blood pressure, or liver disease. It is important to follow the prescribed application schedule and consult a healthcare provider before use. Store the patches at room temperature and keep them out of reach of children.

Avoid Interactions

Xulane 150 mcg/d may interact with certain medications, including those that affect liver enzymes. Alcohol and other substances that impact liver function should be used with caution. Always inform your healthcare provider about all medications and supplements you are taking.

Frequently Asked Questions

Xulane 150 mcg/d is primarily used for contraception, preventing ovulation and fertilization through transdermal hormone delivery.

The Xulane patch is applied once a week for three weeks, followed by a week without the patch.

Common side effects may include skin irritation, nausea, headache, and breast tenderness.

Xulane should be used with caution in individuals with a history of blood clots. Consult a healthcare provider before use.

Store Xulane patches at room temperature and keep them out of reach of children.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.